u/Independent-Cress382

A pension fund filed a lawsuit claiming Cava insiders (including founder Ronald Shaich) sold over $2 billion in stock while the company hyped a bogus growth narrative. The lawsuit casts doubt on Cava’s fundamental story; if the court finds merit, the stock could correct sharply as investor trust erodes and potential penalties emerge. The insider selling pattern and legal risk create a bearish catalyst; shorting CAVA on weakness is a speculative but logical trade. The lawsuit may be dismissed or settled without material impact; Cava’s actual business performance could remain strong, delaying any downside.

Duolingo's stock has collapsed from $530 to $91 in 8 months and just dropped another 22% after-hours due to a poor forecast. The extreme negative momentum and poor forward guidance suggest the stock's decline is justified and may continue as the market digests the bad news. The author's post, by highlighting the massive price drop and the latest negative catalyst, strongly implies a bearish outlook and that the stock is a poor investment, making it a candidate for a short position. The stock may be oversold after such a dramatic drop, leading to a short-term relief rally or "dead cat bounce." A potential overreaction to the guidance could create a buying opportunity for contrarian investors. TICKER - DIRECTION

The user quotes Wall Street analyst ratings showing an average 12-month price target of $232.22, representing a 97.72% upside from the price of $117.45. The significant discrepancy between the current, post-crash stock price and the consensus analyst price target suggests the stock is now deeply undervalued and poised for a major recovery. The user sarcastically contrasts Wall Street analysts with "WSB analysts," but in doing so, presents a clear, data-backed bullish case. The trade idea is to buy the stock at its depressed price, targeting the significant upside potential identified by professional analysts. Analyst price targets are often slow to update following major news and may not have fully incorporated the new, poor guidance. The analysts could simply be wrong, and the stock may continue to decline.